EcoDrugPlus

Ensembl ID : ENSOJAG00000012621
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSOJAG00000019601
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSOJAG00000012608
Gene Symbol: -
Cross references: -
150 Possible Orthologues:

Ensembl ID : ENSOJAG00000004329
Gene Symbol: -
Cross references: -
380 Possible Orthologues:

Ensembl ID : ENSOJAG00000012093
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSOJAG00000019998
Gene Symbol: -
1 Cross references
360 Possible Orthologues:

Ensembl ID : ENSOJAG00000007472
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSOJAG00000003930
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSOJAG00000020241
Gene Symbol: RPS7
1 Cross references
357 Possible Orthologues:

Ensembl ID : ENSOJAG00000009474
Gene Symbol: RPL19
1 Cross references
317 Possible Orthologues:

Ensembl ID : ENSOJAG00000020307
Gene Symbol: RPL13
1 Cross references
275 Possible Orthologues:

Ensembl ID : ENSOJAG00000009673
Gene Symbol: RPS25
1 Cross references
450 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).